Ajankohtaista

Rohkeat biologit – Intohimo ja innovatiivisuus suunnannäyttäjinä -seminaari Jyväskylässä 6.11.

6.11.2018 | Ajankohtaista

Järjestimme seminaarin teemalla Rohkeat biologit – Intohimo ja innovatiivisuus suunnannäyttäjinä. Puhujina seminaarissa olivat Virpi Muhonen (Askel Healthcare Oy), Leona Gilbert (Te?ted Oy), Leena Valmu (dosentti, lasten- ja nuortenkirjailija) ja Matti Jalasvuori (akatemiatutkija). Mika Nurmikolu Evogenom Oy:sta joutui perumaan osallistumisensa, mutta saimme kuitenkin Suomen Akatemian akatemiapalkinnon saaneen Matin mukaan seminaariimme! Puheet olivat äärimmäisen inspiroivia ja opiskelijat olivat selvästi kiinnostuneita erilaisista uratarinoista. Keskustelu jatkui rennosti viinin ja snacksien merkeissä 😊

 

Solubiologi-lehti etsii toimittajaa Oulusta!

6.11.2018 | Ajankohtaista

Oletko kiinnostunut tieteellisestä kirjoittamisesta? Kaksi kertaa vuodessa ilmestyvä Solubiologi-lehti etsii uutta toimittajaa Oulusta! Kiinnostuneet voivat ottaa yhteyttä lehden päätoimittajaan, Jenny Joutseneen, jenny.joutsen@abo.fi!

 

Rohkeat Biologit -seminaari HUOMENNA Jyväskylässä klo 14!

5.11.2018 | Ajankohtaista

Tervetuloa Rohkeat Biologit – Intohimo ja innovatiivisuus suunnannäyttäjinä -seminaariimme, joka järjestetään Jyväskylässä huomenna klo 14! Vielä kerkeät ilmoittautumaan mukaan, laita sähköpostia osoitteeseen suomensolubiologit@gmail.com tai ilmoittaudu Korpin kautta, mikäli olet Jyväskylän yliopiston opiskelija. Haluamme muistuttaa, että seminaariin ovat tervetulleita KAIKKI kiinnostuneet, sinun ei tarvitse olla opiskelija tai edes yhdistyksemme jäsen. Mikäli kuitenkin haluat liittyä yhdistyksemme jäseneksi, se onnistuu helposti paikan päällä. Seminaarissamme kuulet innostavia puheita alamme asiantuntijoilta, ja samalla voit verkostoitua opiskelijoiden, työnantajien ja hallituslaistemme kanssa rennosti viinin ja purtavan parissa!

 

Medical Advisor Oncology – Merck Group; Espoo, Southern Finland, Finland

5.11.2018 | Ajankohtaista

Medical Advisor Oncology – Merck Group; Espoo, Southern Finland, Finland

Job description

A career at Merck is an ongoing journey of discovery: our 53,000 people are shaping how the world lives, works and plays through next generation advancements in healthcare, life science and performance materials. For 350 years and across the world we have passionately pursued our curiosity to find novel and vibrant ways of enhancing the lives of others.

Your role: We are looking for a skilled future colleague to manage our therapeutic area medical activities in oncology. You will be responsible to develop and contribute to local medical/study strategy and overall tactics in close collaboration with Head of Medical Affairs in Finland. You will provide medical expertise and education on oncology products and related launches and will ensure optimal positioning of existing products by participating and making active contributions. You will be responsible to establish and maintain the scientific image and reputation of the company within this key binding role between science and business. You will establish and actively manage scientific relations with key customers, for example oncologists, pathologists, surgeons and nurses. This role focuses on internal and external activities, and will be 50% field-based.

Who you are

  • You have a University degree preferably in life sciences (MSc, PhD, Pharm.D. M.D.), advanced degree preferred
  • Scientific/clinical knowledge in oncology is considered as an asset
  • The position requires professional experience of at least 2 years. Prior industry experience and knowledge of medical affairs, regulatory, safety or clinical operations is considered an asset
  • You are a positive team player, self-driven and have excellent collaboration and communication skills
  • You have an ability to manage multiple tasks and tight deadlines with a results-driven attitude
  • You are fluent in Finnish and English

What we offer: At Merck, there are always opportunities to break new ground. We empower you to fulfil your ambitions, and our diverse businesses offer various career moves to seek new horizons. We trust you with responsibility early on and support you to draw your own career map that is responsive to your aspirations and priorities in life. Join us and bring your curiosity to life!

Curious? Apply and find more information at come2merck.com

Research Scientist, in vivo pharmacokinetics – Orion Corporation, Varsinais-Suomi

3.11.2018 | Ajankohtaista

Research Scientist, in vivo pharmacokinetics – Orion Corporation, Varsinais-Suomi

Job description

Orion Corporation operates in more than 20 countries, where we Orionees, 3300 in total, work in all kinds of positions. Among us there are Research Scientists, Laboratory Technicians, Engineers and IT Specialists as well as people working in Production, just to mention some examples. We offer diverse and responsible jobs to our personnel in a truly multi-disciplinary work environment. We encourage people to develop their competences and offer opportunities to affect the job description and creating their own career path at Orion. We are searching for top talents who are ready to share our passion for the work that we do.

Description of position:

We are looking for an in vivo PK scientist to join Orion R&D Discovery PK/PD team in Turku. The position is temporary maternity leave substitution.

In this role you are responsible to participate in Orion R&D projects in different nonclinical phases as a pharmacokinetic expert. Your tasks include planning, executing and overseeing in vivo PK-studies as well as reporting and data-analysis. You work closely with bioanalytical and ADME scientists as well as with biomarker and PD scientists. In addition, you interpret and communicate results effectively to multidisciplinary project teams.

You will be reporting to Head of Discovery PK/PD.

Description of unit:

Discovery PK/PD unit is part of Orion Translational Pharmacology and Safety Sciences platform with facilities in Turku. The organization is responsible for the preclinical PK/PD assessment of new drug candidates during various stages of the drug discovery and development process. The function designs and executes pharmacokinetic and pharmacodynamic studies both in our own facilities and in collaboration with contract research organizations. We support research and development projects at all Orion’s therapy areas.

We Offer:

We offer exciting opportunities to create and have an impact on the future therapies for patients.

We also offer you attractive career development opportunities for using your own strengths for development, highly interesting R&D pipeline and enthusiastic working environment. Appreciation of personnel and constant development are part of our core values.  The culture of Orion R&D is informal and we enjoy working together.

We are passionate about the patient welfare and are The Voice of Science and the Patient – do you share the same values?

The position is located in Turku, Finland.

We expect you to have

    • M.Sc./Ph.D. degree in relevant field of science
    • In depth knowledge in pharmacokinetics
    • Good understanding of nonclinical research
    • A keen understanding of experimental design, underlying scientific principles and the ability to rigorously analyze and interpret results
    • Excellent networking, presentation and communication skills in English
    • Ability to coordinate, prioritize and get things done
    • We also value ability to provide novel solutions and ability to synthesize scientific problems into strategy
    • Enthusiastic, innovative and science-oriented mindset

You are team and goal orientated and cope well with setbacks. You are self-guided and proactive person but in this position will always have team of professionals to work with.
Additional information on the position:

Eija Aho, Head of Discovery PK/PD, R&D, tel. +358 50 966 7675, firstname.surname@orionpharma.com

Please, send your application by 11th of November through our web page www.orion.fi.

Te?ted Oy palkittiin NOME-verkoston kansainvälisessä pitchauskilpailussa

1.11.2018 | Ajankohtaista

https://turkubusinessregion.com/suomalaisyritys-palkittiin-nome-verkoston-kansainvalisessa-pitchauskilpailussa/?fbclid=IwAR07bQ-wmeBATJ4tJnZxlE3LTW3TvG_ytuD_gmmli-RB_hBtvGc5EnyQkhQ

Onnea Te?ted Oy, Leona Gilbert ja tiimi NOME-verkoston pitchauskilpailun voitosta! Muistattehan, että Leona on tulossa Rohkeat Biologit -seminaariimme jakamaan omia ajatuksiaan ja kokemuksiaan bioalalla työskentelystä tiistaina 6.11.! Leona jos joku on oikea ihminen kertomaan innovatiivisuudesta ja rohkeudesta sekä siitä, miten näitä pystyy hyödyntämään omalla urapolullaan. Tervetuloa inspiroitumaan, nähdään Ambiotican YAA303-salissa 6.11. klo 14! Ilmoittaudu mukaan laittamalla sähköpostia osoitteeseen suomensolubiologit@gmail.com tai Korpissa, mikäli olet Jyväskylän yliopiston opiskelija.

 

Study Director In Vivo – Charles River Laboratories, Kuopio, FI

1.11.2018 | Ajankohtaista

Study Director In Vivo – Charles River Laboratories, Kuopio, FI

Job description

For nearly 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

STUDY DIRECTOR IN VIVO

We are looking for scientist with proven track of experience in in vivo neuroscience to join Charles River Discovery Research Service site located in Kuopio, Finland.The position require an expertise in in vivo pharmacological studies in CNS area that enable to discuss and conclude in vivo data from efficacy studies in injury triggered animal models CNS diseases for example ischemia models, TBI, SCI, etc.

In this position you are responsible to lead Client projects in CNS drug discovery field. The Study Director will ensure the scientific excellence of study design, execution, data analysis and reporting. The Study Director will lead execution of the projects working closely with the team. The responsibilities of this position include communication with the Clients in all phases of the projects. The position require an expertise in in vivo animal models of CNS diseases, as well as capabilities to set up and develop new techniques and models in R&D projects. The Study Director will provide scientific input and assist in preparation of marketing materials.

Qualifications

    • Higher education degree in biological science (MSc, MD), preferably PhD degree
    • At least 2-3 years of experience with CNS in vivo work, including proven track of independent project execution and project management
    • Knowledge and practical experience in conducting studies in animal models of ischemia and/or traumatic brain injury and/or spinal cord injury is required, conducting efficacy studies experience will be an asset
    • Understanding and practical experience with in vivo pharmacology studies in CNS area including both genetically modified animal models and surgically/chemically induced models and related behavioral assays
    • Understanding of scientific studies experimental design, underlining scientific principles, and ability to analyze data and interpret results
    • Ability to quickly adapt to challenging research environment and to effectively utilize knowledge and experience in various scientific projects
    • Fluent English oral and written, scientific writing ability, excellent communication skills, interpersonal, and teamwork abilities
    • Good problemsolving skills, ability to coordinate and prioritize
    • Pharmaceutical industry, Preclinical Contract Research Organization or academic post-doctoral experience will be an asset
    • Proven track of people management, ability to mentor and train staff will be as asset

About Discovery

Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and 74 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.

About Charles River

Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.

For more information, please visit www.criver.com.

Muistakaahan ilmoittautua Rohkeat Biologit -seminaariimme!

30.10.2018 | Ajankohtaista

Vielä kerkeää mukaan Rohkeat Biologit -seminaariin, joka järjestetään Jyväskylässä tiistaina 6.11.! Loistava tilaisuus kuulla alamme yrittäjyydestä ja ylipäätään siitä, miten intohimostaan voi räätälöidä itselleen työn. Tule verkostoitumaan alan opiskelijoiden, työnantajien ja Suomen Solubiologit ry:n hallituslaisten kanssa rennosti viinin ja pienen purtavan parissa! Ilmoittaudu mukaan laittamalla sähköpostia osoitteeseen suomensolubiologit@gmail.com tai Korpissa, mikäli olet Jyväskylän yliopiston opiskelija.

 

Several postdoctoral positions are available in cell / developmental / vascular biology in the group of Taija Mäkinen at Uppsala University

29.10.2018 | Ajankohtaista
Post docs in cell / developmental / vascular biology
 
Several postdoctoral positions are available in the group of Taija Mäkinen at Uppsala University. The lab studies fundamental mechanisms of tissue morphogenesis in the vascular system. The aim is to understand how endothelial cells communicate with each other and the tissue environment to co-ordinate vascular morphogenesis and formation of functionally specialized blood and lymphatic vessel types. To do so, the group utilises advanced mouse genetic tools and state-of-the-art cell and molecular biology techniques (including single cell RNA sequencing, flow cytometry, confocal, light-sheet and super-resolution microscopy). For more details about the group’s research please see: http://www.makinenlab.com/
 
Selected recent publications from the laboratory:
Zhang et al, Nat Commun 2018; Frye et al, Nat Commun 2018; Zhang et al, Development 2018; Wang et al, Development 2017; Martina-Almedina et al, J Clin Invest 2016; Martinez-Corral et al, Circ Res 2015; Stanczuk et al, Cell Rep 2015; Tatin et al, Dev Cell 2013; Lutter et al, J Cell Biol 2012; Bazigou et al, J Clin Invest 2011.
 
Work description:
The selected candidate(s) will work on one of the following topics: 1) functional characterisation of tissue-specific lymphatic endothelial progenitor cells (as part of an ERC-funded project), 2) identification and functional characterisation of vascular-bed specific genes, or 3) elucidation of disease mechanisms in vascular malformations. In addition, one position will be in collaboration with the group of Ingvar Ferby at Uppsala University (http://www.imbim.uu.se/forskargrupper/cancer/ferby-ingvar/), exploring how vesicular trafficking and compartmentalisation of growth factor receptors instruct behaviour of epithelial and endothelial cells using e.g. live-cell imaging approaches.
 
Qualifications:
We are looking for highly motivated individuals with a PhD and research background in molecular or cell biology, developmental biology or biochemistry, and a proven track record of successful scientific work. Strong background in molecular/cell biology, mouse genetics, flow cytometry and/or imaging is required.
 
How to apply:
To apply, please send your CV together with the names of three references and a short description of yourself and the motivation to join the group to: taija.makinen@igp.uu.se
 
The position is open until 28 December 2018, or until suitable candidate(s) is found.

PhD PostDoc positions in Research Programs Unit of the Faculty of Medicine UH

22.10.2018 | Ajankohtaista
Research Programs Unit of the Faculty of Medicine is a top-quality research environment at the University of Helsinki, a leading European university with a strong life science research, and cancer research in particular. The unit is located in Biomedicum Helsinki close to the Helsinki University Central Hospital, and it provides state-of-the-art core facilities for genomics, proteomics, imaging, and bioinformatics.
PhD candidate and post-doctoral fellow (or bioinformatician/computational biologist) in the field of functional genomics (starting early 2019)

We are seeking a highly motivated and talented individual for working in the field of functional epigenomics. The focus of the lab is to investigate the interplay between transcription factors and oncogenes using modern genome-wide methods for regulatory genomic features and chromatin architecture. The group belongs to the Applied Tumor Genomics Program (starting from 2019) in the Research Programs Unit of the Faculty of Medicine in University of Helsinki providing an excellent research environment with strong focus on cancer research.

We offer a position in a young, multi-disciplinary and teamwork-oriented group that will be comprised of both computational and wet-lab scientists. The ideal candidates will be involved in generation and analysis of functional genomics datasets from next-generation sequencing methods such as ATAC-seq, Hi-C, ChIPseq, as well as CRISPR-based approaches.

– For post-doctoral fellows, the candidate should have a PhD degree in computational biology, bioinformatics or other fields with strong background in programming languages. Demonstrated skill and prior experience in the analysis of high-throughput omics datasets is required and candidates with proven track record in terms of publications will be given preference.

– For PhD students, the candidate should have a Master’s degree in any field of life sciences, other translational programs or quantitative sciences with a particular interest in molecular biology and functional genomics. A good understanding of biochemistry, genomics experiments and bioinformatics is expected. Prior experience in generating experimental omics datasets is an asset but not a requirement.

With English as a working language, excellent oral and written communication skills are required. Salaries are based on the salary system for Finnish universities (YPJ). Details on the project and other informal queries are very welcome and should be sent to biswajyoti.sahu@helsinki.fi. Applications will be considered on a rolling basis till a suitable candidate is found.

Applications should be in form of a single-pdf containing a one-page cover letter describing your research goals, interest and motivation together with recent curriculum vitae (CV) including publications. In addition, two-three reference letters with their contact details must be sent to: biswajyoti.sahu@helsinki.fi

Research Programs Unit
Faculty of Medicine
University of Helsinki
Tutkimusohjelmayksikkö, PL 63 (Haartmaninkatu 8), FI-00014 Helsingin yliopisto Forskningsprogramenheten, PB 33 (Haartmansgatan 4), FI-00014 Helsingfors universitet, Research Programs Unit, POB 63 (Haartmaninkatu 8), FI-00014 University of Helsinki, https://www.helsinki.fi/en/faculty-of-medicine/research-programs-unit